Genfit License

Anonymous

Guest
$136M upfront to license elifibranor and $407M in potential additional milestones, I suppose it's better than the deal for palovarotene...but then that deal was an epic waste of money.
 






$136M upfront to license elifibranor and $407M in potential additional milestones, I suppose it's better than the deal for palovarotene...but then that deal was an epic waste of money.

Yeah, it’ll probably go nowhere, but at least it’s not pissing away $1 billion like the Clementia debacle. You can thank that crazy idiot woman Ivana who used to head BD for that. I think she’s running a Gulag in Eastern Europe now.